Computational Models Uncover hLL-37's Dynamic Mechanism for Bacterial Membrane Disruption
Background
hLL-37 is a crucial human antimicrobial peptide (AMP), a key component of our innate immune system, renowned for its broad-spectrum activity against various bacteria and even some viruses. Its primary mechanism of action often involves directly disrupting microbial membranes, leading to cell death. However, the precise molecular dynamics and intricate conformational changes that hLL-37 undergoes during its interaction with and insertion into bacterial membranes, especially how it transitions into membrane-disrupting states, remain incompletely understood at an atomic and kinetic level. This knowledge gap hinders rational design of improved AMPs.
Results
The sophisticated MSMs successfully identified five distinct metastable states for hLL-37 within the membrane environment: an initial electrostatic surface-bound state, two intermediate partially inserted states, a fully transmembrane pore-forming state, and a transient aggregated state. The kinetic analysis revealed that the transition from the surface-bound to the stable pore-forming state occurred with a calculated rate constant of 0.075 ns⁻¹, indicating a rapid and efficient insertion process. > The most critical finding was that hLL-37 exhibited a remarkable 3.1-fold increase in its alpha-helical content (from 35% in solution to 108% relative to initial state, effectively 73% absolute) upon full membrane insertion, a conformational change essential for stabilizing the transmembrane pore structure. Detailed analysis further revealed that specific hydrophobic residues like Phe17, Leu20, and Ile23 were disproportionately crucial for initiating membrane insertion, showing a 58% higher interaction frequency with the hydrophobic lipid core compared to other residues. The study also predicted that the peptide forms transient, toroidal pores with an average diameter of 1.8 nm and a lifetime of approximately 250 ns, consistent with its known membrane-lytic activity and providing atomic resolution to this mechanism.
Why It Matters
This study provides unprecedented atomic-level and kinetic insight into the dynamic mechanism of hLL-37's membrane disruption, a fundamental aspect of its potent antimicrobial function and a key process in innate immunity. Understanding these precise conformational transitions and the roles of specific residues could pave the way for rationally designing novel, more potent antimicrobial peptides with enhanced membrane selectivity, improved stability, and reduced potential for host toxicity. Future research should focus on experimentally validating these computational predictions using techniques like solid-state NMR or fluorescence spectroscopy, and exploring targeted modifications to hLL-37 to optimize its therapeutic potential against drug-resistant pathogens, potentially leading to new clinical candidates.